Taruna Katyal | Pharmacology | Best Researcher Award

Dr. Taruna Katyal | Pharmacology | Best Researcher Award

ICMR- India

Author Profile

Early Academic Pursuits 🎓

Dr. Taruna Arora’s journey in the field of pharmacy began with a solid foundation in academic excellence. She earned her Bachelor of Pharmacy (B. Pharm) degree from the Department of Pharmaceutical Sciences at M.D. University, Rohtak, India in 2005, securing a commendable 71%. Driven by a passion for pharmacological research, she pursued her Master of Pharmacy (M. Pharm) in Pharmacology at I.S.F. College of Pharmacy, Punjab Technical University, Jalandhar, graduating in 2007 with an impressive 71%. Her quest for deeper knowledge led her to Uttarakhand Technical University, Dehradun, where she completed her Ph.D. in Pharmacology from 2010 to 2014. Her doctoral research focused on the potential roles of vascular endothelial nitric oxide synthase (eNOS), caveolin-1, and haemoxygenase in the development of experimental diabetic nephropathy in rats, contributing significant insights to the field of diabetic complications and vascular health. This work laid the groundwork for her continued research in the broader field of pharmacology and therapeutic interventions.

Professional Endeavors 🏛️

Dr. Arora’s professional career spans over a decade and showcases her diverse expertise in both academic and research roles. She began as a Lecturer at Shivdan Singh Institute of Management and Technology, Aligarh, in 2007, followed by her position as an Assistant Professor at I.S.F. College of Pharmacy, Moga, Punjab from 2008 to 2012, where she honed her teaching, research, and administrative skills. In 2012, she moved to P.D.M College of Pharmacy, Bahadurgarh, Haryana, serving as an Assistant Professor until 2014, where she was actively involved in nurturing future pharmacists and conducting research.

In 2015, Dr. Arora joined the ICMR National Institute of Malaria Research (NIMR), New Delhi as a Post-Doctoral Fellow, where she conducted pivotal research on the qualitative and quantitative assessment of antimalarials at selected study sites across India. Her tenure at ICMR deepened her research focus on malaria and other infectious diseases, contributing to public health advancements. From 2019 to 2024, Dr. Arora worked as Scientist ‘C’ and later Scientist ‘D’ in the RCN Division of the Indian Council of Medical Research (ICMR), where she coordinated and monitored national task forces, research projects, and fellowships. She also served as the Public Grievance Officer and RTI Officer, ensuring transparency and addressing public concerns effectively. Her responsibilities included compiling monthly research and administrative activities, showcasing her commitment to both scientific and administrative excellence.

Contributions and Research Focus 🔬

Dr. Arora’s research has been impactful, particularly in the areas of pharmacology, malaria elimination, and public health. Her post-doctoral work at ICMR focused on evaluating antimalarial drugs, which have critical implications for effective treatment strategies in endemic regions. Her doctoral work, emphasizing the vascular mechanisms involved in diabetic nephropathy, added valuable data to understand disease progression and potential therapeutic interventions. As a Scientist at ICMR, she contributed to the Malaria Elimination Research Alliance India (MERA INDIA), fostering collaboration between research institutes to push forward malaria elimination goals in India.

Accolades and Recognition 🏆

Dr. Arora’s career has been marked by significant recognition for her contributions. Her involvement in national task forces and leadership in coordinating research projects underscore her expertise and dedication. As a public servant and researcher, she has ensured that scientific research aligns with national health objectives, earning her respect and acknowledgment from peers and the scientific community.

Impact and Influence 🌍

Dr. Arora’s work has had far-reaching effects on public health policies and practices, especially in the area of malaria research and elimination. Her coordination of research initiatives and her strategic input have supported data-driven decisions that contribute to disease control and management. Additionally, her contributions to pharmacological education have shaped the careers of countless students who have benefited from her mentorship and training.

Legacy and Future Contributions 🔮

Dr. Arora’s legacy is one of dedication, scholarship, and an unwavering commitment to public health and pharmacological research. Her work is poised to inspire future generations of researchers and policymakers. As she continues to lead initiatives at ICMR, her impact will undoubtedly resonate in future public health advancements, especially in the context of disease prevention and therapeutic interventions. Dr. Arora’s expertise and experiences provide a roadmap for how research can translate into actionable health outcomes, ensuring her legacy endures in the scientific and health communities.

Citations

A total of 931 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations        931
  • h-index          46
  • i10-index       11

Notable Publications 

  • Title: Unveiling the complex interplay between gut microbiota and polycystic ovary syndrome: A narrative review
    Authors: Gautam, R., Maan, P., Patel, A.K., Vasudevan, S., Arora, T.
    Journal: Clinical Nutrition
    Year: 2024.
  • Title: Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women
    Authors: Ganie, M.A., Chowdhury, S., Malhotra, N., Arora, T., Kulkarni, B.
    Journal: JAMA network open
    Year: 2024.
  • Title: Unveiling the Role of Artificial Intelligence (AI) in Polycystic Ovary Syndrome (PCOS) Diagnosis: A Comprehensive Review
    Authors: Verma, P., Maan, P., Gautam, R., Arora, T.
    Journal: Reproductive Sciences
    Year: 2024.
  • Title: Adropin may regulate ovarian functions by improving antioxidant potential in adult mouse
    Authors: Maurya, S., Tripathi, S., Arora, T., Singh, A.
    Journal: Journal of Steroid Biochemistry and Molecular Biology
    Year: 2024.
  • Title: Common Hematological Reference Indices Among Healthy Reproductive Age Indian Women-Data Subset from Nationwide Study
    Authors: Ganie, M.A., Chowdhury, S., Suri, V., Shukla, A., Arora, T.
    Journal: Indian Journal of Hematology and Blood Transfusion
    Year: 2024.

Ananda Kumar Chettupalli | Pharmacy | Best Researcher Award

Dr. Ananda Kumar Chettupalli | Pharmacy | Best Researcher Award

Chettupalli Galgotias University, India

Author Profile

📚 Early Academic Pursuits

Dr. Chettupalli’s academic journey began with his foundational education in pharmacy. He obtained his Bachelor of Pharmacy degree in 2010 from Nirmala College of Pharmaceutical Sciences, affiliated with Acharya Nagarjuna University, where he gained a solid grounding in pharmaceutical principles and practices. During his undergraduate studies, Dr. Chettupalli demonstrated a keen interest in drug formulation and delivery systems, laying the groundwork for his future contributions to the field.Following his undergraduate studies, Dr. Chettupalli pursued his Master of Pharmacy (M.Pharm) in 2012 from A.M. Reddy College of Pharmacy, also affiliated with Acharya Nagarjuna University. Specializing in Pharmaceutics, he explored innovative methods of drug formulation. His M.Pharm thesis, titled “Development of Itraconazole Immediate Release Pellets by Using HPMC Loaded in Gelatin Capsules,” showcased his expertise in formulation science and his focus on enhancing drug solubility and bioavailability—challenges central to modern pharmacotherapy.

🧪 Research and Contributions

Dr. Chettupalli earned his Ph.D. in Pharmaceutical Sciences from Shri Jagdish Prasad Jhabarmal Tibrewala University in Rajasthan in 2016. His doctoral research, “Design and Characterization of Carvedilol Ethosomes as a Transdermal Drug Delivery System,” involved developing a transdermal delivery system for Carvedilol, a widely used cardiovascular drug. This innovative approach aimed to optimize therapeutic efficacy while minimizing side effects, emphasizing his focus on patient-centered pharmacology. His research marked an important step toward more effective and convenient treatment methods for chronic diseases through enhanced transdermal drug delivery systems.

🏆 Professional Endeavors and Experience

With a career spanning 12 years and 8 months, Dr. Chettupalli has gained extensive experience as an academic and researcher. Throughout his career, he has demonstrated a strong commitment to pharmaceutical education and research, bridging the gap between theory and practice. His experience in teaching has allowed him to mentor future pharmacists and pharmaceutical scientists, imparting both foundational knowledge and advanced skills in drug development and delivery systems.In addition to his role as an educator, Dr. Chettupalli has actively engaged in research focused on formulation science, nanotechnology, and transdermal systems, contributing to the ongoing evolution of pharmaceutical technology. His work on the development of immediate-release formulations and transdermal applications reflects his dedication to improving patient compliance and therapeutic outcomes through innovative drug delivery strategies.

🌍 Impact and Influence

Dr. Chettupalli’s research on transdermal drug delivery systems has contributed significantly to the advancement of non-invasive treatment modalities. By developing Carvedilol ethosomes for transdermal administration, he has provided a model for enhancing drug penetration through the skin barrier, potentially revolutionizing the treatment options available for patients with cardiovascular conditions. His contributions to formulation science have paved the way for more effective therapies with fewer adverse effects, which is particularly important in the management of chronic conditions.Moreover, Dr. Chettupalli’s influence extends beyond his immediate research, as his expertise in formulation and nanotechnology continues to inspire a new generation of pharmaceutical scientists. His commitment to bridging clinical relevance with academic rigor serves as a model for aspiring researchers in the field.

🏅 Accolades and Recognition

Over the years, Dr. Chettupalli has received recognition for his contributions to the field of pharmaceutics. His work has been appreciated by academic peers and students alike, who recognize his dedication to quality research and his skill in making complex topics accessible. While specific awards and honors may not be listed here, Dr. Chettupalli’s ongoing influence as an educator and researcher serves as a testament to his excellence in the field.

💡 Legacy and Future Contributions

Dr. Chettupalli’s impact on pharmaceutical sciences, particularly in the area of drug delivery systems, is likely to endure for years to come. As he continues his work in pharmaceutics, he is poised to make further contributions to transdermal drug delivery and nanotechnology applications. His research on ethosomes has the potential to inspire further studies on the transdermal delivery of other therapeutic agents, potentially offering new treatments for a range of conditions.Looking to the future, Dr. Chettupalli is expected to expand his research on innovative drug delivery mechanisms, possibly incorporating advanced nanotechnology and biodegradable polymers to develop environmentally sustainable and patient-friendly pharmaceuticals. His career reflects a dedication to both scientific advancement and patient welfare, and his work will likely continue to influence the fields of formulation science and clinical pharmacology.

🌟 Conclusion: A Lasting Contribution

Dr. Ananda Kumar Chettupalli’s career in pharmaceutical sciences exemplifies the power of combining academic knowledge with practical innovation. From his early studies in pharmacy to his specialized work in transdermal drug delivery, he has contributed significantly to the fields of pharmaceutics and drug formulation. His ongoing dedication to education and research underscores his commitment to improving healthcare and advancing the pharmaceutical sciences, and his work will continue to benefit both students and patients for years to come.

Citations

A total of 228 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         228
  • h-index           19
  • i10-index        09

Notable Publications 

  • “Improved Transdermal Delivery of Anti-hypertensive Drug Loaded Nanostructured Lipid Carriers: Statistical Design, Optimization, Depiction and Pharmacokinetic Assessment”
    • Authors: Chettupalli, A.K., Avula, P.R., Chauhan, V.
    • Journal: Current Drug Therapy, 2024.
  • “Design Formulation of Nanospanlastic Novel Carriers as a Promising Approach to Enhanced Bioavailability in Intranasal Drug Delivery for Sinusitis: Statistical Optimization and In vitro and In vivo Characterization”
    • Authors: Chettupalli, A.K., Ajmera, S., Kuchukuntla, M., Palanivel, V., Katta, S.
    • Journal: Current Nanomedicine, 2024.
  • “Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine: Statistical Optimization and Pharmacological Evaluations”
    • Authors: Unnisa, A., Chettupalli, A.K., Alazragi, R.S., Mohamed, O.A., Hussain, T.
    • Journal: Pharmaceuticals, 2023.
  • “Quality by Design Approach for Preparation, Characterization, and Statistical Optimization of Naproxen Sodium-loaded Ethosomes via Transdermal Route”
    • Authors: Chettupalli, A.K., Ajmera, S., Amarachinta, P.R., Manda, R.M., Jadi, R.K.
    • Journal: Current Bioactive Compounds, 2023.
  • “In silico elucidation of plausible anti-obesity activity by Withaferin-A compound targeting alpha-amylase”
    • Authors: Alafnan, A., Chettupalli, A.K., Unnisa, A., Anupama, B., Lakshmi, K.N.V.C.
    • Journal: European Review for Medical and Pharmacological Sciences, 2023.

Radha Goel | Pharmacology | Best Researcher Award

Dr. Radha Goel | Pharmacology | Best Researcher Award

Lloyd Institute of Management and Technology, Greater Noida, India

Author Profile

🎓 Early Academic Pursuits

Dr. Radha Goel’s academic journey began with a solid foundation in pharmaceutical sciences. She completed her Bachelor of Pharmacy from Hamdard University, New Delhi, in 2002, securing a commendable 67.3%—a significant achievement in a challenging field. Driven by her passion for pharmacology, she further pursued a Master’s degree in Pharmacology at the same university, graduating in 2005 with an impressive 74.8% score. This master’s program provided her with an in-depth understanding of drug interactions, pharmacodynamics, and pharmacokinetics, honing her expertise in pharmacological sciences and setting her on the path to becoming an accomplished researcher and educator.Dr. Goel’s academic journey culminated in a Doctorate in Pharmacology from Jaipur National University in 2012. Her doctoral studies added depth to her research acumen and significantly broadened her knowledge in pharmacology. Additionally, she completed a Post Graduate Diploma in Clinical Research from IGMPI, Gurgaon, in 2016 with a 75.21%, equipping herself with specialized skills crucial for clinical research roles.

👩‍🏫 Professional Endeavors

Dr. Goel’s professional trajectory has been both diverse and impactful, spanning over 17 years in academia and industry. She began her career as a Clinical Research Associate at Jagsonpal Pharmaceuticals Ltd., where she gained hands-on experience in clinical trials and pharmaceutical research from August 2005 to February 2006. This early exposure provided her with practical insights into the industry and set the stage for her transition into academia.In March 2006, Dr. Goel took on her first academic role as a Lecturer at KIET College of Pharmacy, where she remained until August of the same year. Her passion for teaching led her to the Institute of Technology and Science (I.T.S.), Muradnagar, Ghaziabad, where she served in various roles from August 2006 to November 2023. Rising from Lecturer to Assistant Professor, then Associate Professor, and finally Professor, she contributed significantly to the institution’s growth and academic excellence. Currently, she is a Professor at the Lloyd Institute of Management and Technology, Greater Noida, a position she has held since November 11th, 2023, where she continues to inspire the next generation of pharmacologists.

🔬 Contributions and Research Focus

As an educator and researcher, Dr. Goel’s contributions to pharmacology are remarkable. With her background in clinical research and pharmacology, she has focused on areas like drug efficacy, patient safety, and pharmacovigilance, enhancing her students’ understanding of drug interactions, therapeutic protocols, and clinical best practices. Her work as an Animal House In-charge (CCSEA Nominee) is especially noteworthy, as it highlights her commitment to ethical standards in research involving animal subjects, ensuring that all practices comply with regulatory guidelines.Her hands-on approach has allowed her to mentor countless students, guiding them in practical experiments and instilling in them the ethical and technical knowledge required in clinical research. Dr. Goel’s focus on translational research—bridging laboratory findings with clinical applications—continues to influence her teaching, ensuring her students gain real-world insights that enhance their readiness for the pharmaceutical industry.

🏆 Accolades and Recognition

Throughout her career, Dr. Goel has been recognized for her academic and professional achievements. Her expertise in pharmacology and clinical research has made her a sought-after figure in academia, and her appointments to senior roles at various institutions speak to her capabilities and influence. As a CCSEA Nominee and Animal House In-charge, she is acknowledged for her commitment to research ethics and animal welfare in pharmaceutical studies, a role that also reflects her peers’ and students’ respect and trust in her guidance.Dr. Goel’s high performance in her Post Graduate Diploma in Clinical Research from IGMPI and her advanced qualifications in pharmacology have garnered her respect within the academic and research community. Her progression to the role of Professor attests to her dedication, and her continued presence in educational institutions is a testament to her contributions to the field.

🌟 Impact and Influence

Dr. Goel has had a lasting impact on the field of pharmacology, particularly in the Greater Noida and Ghaziabad academic communities. Her deep expertise, combined with a practical approach, has empowered students with knowledge and skills that have helped many succeed in their careers. Her ethical commitment as the Animal House In-charge demonstrates her advocacy for responsible research, influencing a generation of researchers to prioritize ethical standards in their work.Dr. Goel’s influence extends beyond her immediate role as a professor; she has also contributed to academic program development, curriculum enhancement, and the establishment of rigorous academic standards at institutions like I.T.S., Muradnagar, and Lloyd Institute of Management and Technology. Her dedication to fostering a culture of excellence in pharmacology has positively impacted her students, colleagues, and the institutions with which she has been affiliated.

🌍 Legacy and Future Contributions

Looking forward, Dr. Goel’s commitment to pharmacology and clinical research will continue to inspire future healthcare professionals and researchers. Her dedication to educational mentorship, combined with her extensive research experience, positions her to make even greater contributions to the field. As a professor and a leader, she remains a source of guidance and support for her students, helping to mold the future of pharmacology with her knowledge, values, and expertise.In summary, Dr. Radha Goel’s journey from academia to a seasoned professional and dedicated educator stands as a testament to her passion for pharmacology, commitment to ethical research, and her profound influence on students and peers alike. Her story is a reminder of the impact that dedicated educators and researchers can have on their field and the generations to come. 🌱

Citations

A total of 95 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         95
  • h-index           27
  • i10-index        05

Notable Publications 

  • “Nanostructured lipid carriers: Enhancing herbal medicine delivery”
    • Authors: Goel, R., Mishra, R., Singh, N., Singh, R., Gaur, P.K.
    • Journal: Lipid Based Nanocarriers for Drug Delivery, 2024.
  • “Formulation of Phytosomes Containing Rubia cordifolia Extract for Neuropathic Pain: In Vitro and In Vivo Evaluation”
    • Authors: Kumar, N., Goel, R., Ansari, M.N., Puri, D., Singh, M.
    • Journal: ACS Omega, 2024.
  • “Advancing Aluminum-Based Composites with Fly Ash and SiC Reinforcement through Stir Casting”
    • Authors: Abood, A.S., Jisha, P.K., Karuna, G., Goel, R., Chandra, P.K.
    • Journal: E3S Web of Conferences, 2024.
  • “Enhancing Aluminum-Based Composite Manufacturing: Leveraging Si3N4 Reinforcement via Friction Stir Process”
    • Authors: Singh, H., Goel, R., Nagpal, A., Karthiyayini, J., Ahmed, R.
    • Journal: E3S Web of Conferences, 2024.
  • “Nanophytosomal Gel of Heydotis corymbosa (L.) Extract against Psoriasis: Characterisation, In Vitro and In Vivo Biological Activity”
    • Authors: Singh, N., Shaikh, A.M., Gupta, P., Singh, S., Vinayak, C.
    • Journal: Pharmaceuticals, 2024.

Narayanan Jayasankar | Pharmacology | Young Scientist Award

Dr. Narayanan Jayasankar | Pharmacology | Young Scientist Award

SRM College of Pharmacy, SRM Institute of Science and Technology, India

Author Profile

Early Academic Pursuits 🎓

Dr. J. Narayanan’s academic journey began with a deep interest in pharmacy, particularly pharmacology, which laid the foundation for his future endeavors in research and development. He completed his Master of Pharmacy in Pharmacology and pursued a Ph.D. in Pharmacy, specializing in data collection and analytical studies. Throughout his academic years, Dr. Narayanan was recognized for his exceptional intellect and dedication to his studies. His commitment to excellence was reflected in his achievements, notably earning the Gold Medal during both his Undergraduate and Postgraduate programs. These accolades were not only a testament to his academic prowess but also highlighted his passion for pharmacology and scientific discovery. 🎖️

Professional Endeavors 💼

Dr. Narayanan’s professional career took a significant leap as he joined the SRM Institute of Science and Technology, Kattankulathur, Chennai, where he currently serves as an Assistant Professor (Grade 2). With a rich blend of research and teaching expertise, he has been a key contributor to the institution’s growth and academic excellence. Over the years, he has demonstrated a remarkable ability to manage multiple projects, guiding both Undergraduate (UG) and Postgraduate (PG) students in pharmacy-related studies. His role as an academic researcher and lecturer is a reflection of his versatile approach to education—engaging in both individual hands-on R&D work and leading teams in various research projects. 🔬

His teaching methodology combines theoretical knowledge with practical insights, which enables students to grasp complex pharmacological concepts and their real-world applications. Furthermore, his involvement in government proposals for developmental tests, especially concerning herbal and isolated compounds, illustrates his forward-thinking approach to advancing the pharmaceutical field. 📚

Contributions and Research Focus 🔍

Dr. Narayanan’s research focus centers on the intricate relationship between pharmacology, drug discovery, and data analytics. His expertise in data collection and analytical methodologies has been invaluable in the study and testing of herbal and isolated compounds, which are vital for pharmaceutical advancements. He has consistently contributed to research projects aimed at improving the efficacy and safety of pharmacological substances, helping to bridge the gap between academic theory and industry practice.As an integral part of the Research and Development (R&D) teams he leads, Dr. Narayanan has worked on numerous government-funded projects focused on drug safety testing, herbal drug development, and pharmacovigilance. His meticulous research and analytical abilities make him a standout figure in his field, especially in the areas of data collection, processing, and reporting. His passion for research extends to both pharmacological studies and new drug formulations, contributing greatly to the evolving landscape of pharmaceutical sciences. 🧬

Accolades and Recognition 🏅

Dr. Narayanan has earned numerous accolades throughout his career, most notably being awarded the Gold Medal for academic excellence during both his undergraduate and postgraduate studies. This recognition not only highlights his academic diligence but also serves as a marker of his dedication to pharmacology and research. He has also been recognized as a topper in his Postgraduate program, a distinction awarded to those who excel in their specialization in pharmacology.His contributions to pharmaceutical research have earned him respect within the academic and scientific communities. Additionally, his leadership in research teams and his innovative approach to government research proposals demonstrate his commitment to improving pharmaceutical practices. His ability to balance academic responsibilities with research leadership showcases his exceptional management and organizational skills. 🏆

Impact and Influence 🌍

Dr. Narayanan’s impact extends beyond the classroom and laboratory; his work influences the broader field of pharmacology and drug development. Through his lectures, academic programs, and research, he has mentored a significant number of students, many of whom have gone on to pursue successful careers in pharmaceutical sciences. His teaching philosophy emphasizes the importance of critical thinking and practical application, preparing students for the rapidly evolving pharmaceutical industry.His leadership in government-funded projects has not only influenced research directions but has also contributed to the advancement of herbal medicine and the standardization of pharmaceutical compounds. The knowledge he imparts to his students, combined with his research expertise, ensures that future generations of pharmacists are well-equipped to address the challenges of modern drug development and healthcare. 🌱

Legacy and Future Contributions 🌟

Dr. Narayanan’s legacy will undoubtedly be marked by his dedication to advancing pharmacological education and research. His work in herbal drug development and data-driven pharmaceutical research has the potential to make a lasting impact on the industry. As he continues to mentor future professionals and contribute to cutting-edge research, his influence will shape the future of pharmacy and pharmacology.Looking ahead, Dr. Narayanan aims to expand his research to explore innovative drug formulations, data analytics in pharmacovigilance, and sustainable drug development practices. His ongoing contributions to government proposals and research initiatives in the field of pharmacology will further solidify his role as a pioneer in the industry. His commitment to improving healthcare through education, research, and drug safety ensures that his future endeavors will continue to have a meaningful impact on both the academic and pharmaceutical communities. 💡Dr. Narayanan’s legacy, driven by his passion for research, teaching, and pharmacological advancements, will undoubtedly continue to inspire and influence the field for many years to come.

Citations

A total of 305 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         305
  • h-index           14
  • i10-index        06

Notable Publications 

  • Title: Quercetin modulates expression of serum exosomal long noncoding RNA NEAT1 to regulate the miR-129-5p/BDNF axis and attenuate cognitive impairment in diabetic mice
    Authors: Wang, H., Jayasankar, N., Thamaraikani, T., Bahrami, A., Akhavan-Sigari, R.
    Journal: Life Sciences
    Year: 2024.
  • Title: Anti-obesity effects of olivetol in adult zebrafish model induced by short-term high-fat diet
    Authors: Reshma, A., Tamilanban, T., Chitra, V., Chakravarthy, S., Selvaraj, S.
    Journal: Scientific Reports
    Year: 2023.
  • Title: Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation
    Authors: Chehelgerdi, M., Chehelgerdi, M., Allela, O.Q.B., Amin, A.H., Akhavan-Sigari, R.
    Journal: Molecular Cancer
    Year: 2023.
  • Title: Role and mechanistic actions of protein kinase inhibitors as an effective drug target for cancer and COVID
    Authors: Narayanan, J., Tamilanban, T., Kumar, P.S., Kathiravan, M.K., Arockiaraj, J.
    Journal: Archives of Microbiology
    Year: 2023.
  • Title: Nanogels as novel drug nanocarriers for CNS drug delivery
    Authors: Manimaran, V., Nivetha, R.P., Tamilanban, T., Ramachawolran, G., Selvaraj, S.
    Journal: Frontiers in Molecular Biosciences
    Year: 2023.

Prasad Neerati | Pharmacology | Best Researcher Award

Prof. Prasad Neerati | Pharmacology | Best Researcher Award

Kakatiya University, India

Author Profile

Early Academic Pursuits 🏫

Prof. Neerati Prasad’s academic journey began with a solid foundation in the sciences. He completed his Secondary School Certificate (SSC) in 1991 with a first-class division, securing 74.16% marks. His thirst for knowledge continued as he excelled in his Intermediate studies, achieving 89.53% in 1994 under the Board of Technical Education. His academic journey took a decisive turn when he pursued his undergraduate degree at Kakatiya University, Warangal, where he graduated in 1999 with 65.80% marks. His passion for pharmaceutical sciences grew stronger during his postgraduate studies, also at Kakatiya University, where he emerged as a University Topper 🏆 in 2002, with a distinction and a remarkable 75.50%.Prof. Prasad’s pre-PhD academic qualifications were equally impressive, as he continued his studies at Kakatiya University, securing 70.1% marks in 2007. This solid academic grounding paved the way for his remarkable research career.

Professional Endeavors 👨‍🏫

With 16 years of experience teaching postgraduate (P.G.) classes and 18 years of undergraduate (U.G.) teaching, Prof. Neerati Prasad has been a pillar in the academic world. His dedication to nurturing young minds and guiding them toward excellence is evident in his long-standing role as a professor at Kakatiya University.Beyond teaching, Prof. Prasad’s research contributions have been extensive. He has spent 15 years in research, excluding the years dedicated to his M.Phil. and Ph.D. studies. His research interests are diverse and impactful, spanning Clinical Pharmacokinetics, Drug Transport, Pharmacokinetics and Drug Metabolism, Cancer Metastasis (with a focus on the role of phyto-polyphenols), Toxicological Studies, and the Pharmacological Screening of new chemical entities from natural sources 🌿. These fields of research hold immense significance for the development of novel therapeutic agents, making his work critical for both academia and the pharmaceutical industry.

Contributions and Research Focus 🔬

Prof. Neerati Prasad’s research has been groundbreaking in several key areas. During his M.Pharm., he conducted an insightful study on Bacteremia amongst Leprosy Patients, awarded in June 2002. However, his most notable work came during his Ph.D., where he explored the Isolation and Characterization of probable potential pharmacological agents from animals and their waste. This innovative research, completed in 2007, opened new avenues in pharmacological studies, contributing to the understanding of natural pharmacological agents.Prof. Prasad’s international experience includes his Post-Doctoral Fellowship (PDF) at SRI International in California, USA 🌍. There, he conducted advanced research in Tumor Glycomics, focusing on biomarker discovery, tumor targeting agents, and the regulation of metastasis by endogenous angioinhibitors. His work at the intersection of pharmacology and cancer research has contributed to a better understanding of metastasis and cancer treatment, positioning him as a key researcher in the field of oncology.

Accolades and Recognition 🏅

Prof. Prasad’s academic and research excellence has not gone unnoticed. He is a recipient of the prestigious C.V. Raman Fellowship, awarded by the University Grants Commission (UGC). This fellowship is given to distinguished scholars to encourage high-quality research. Additionally, during his Ph.D. journey, he was awarded a UGC Research Fellowship for his exceptional work. These accolades reflect not only his dedication to the field but also the high regard in which he is held by the academic community.

Impact and Influence 🌍

Prof. Neerati Prasad’s work has had a profound impact on the fields of pharmacology, oncology, and pharmaceutical sciences. His research on Cancer Metastasis and the role of natural compounds in regulating metastasis has been instrumental in developing new approaches to cancer treatment. Moreover, his contributions to Clinical Pharmacokinetics and Drug Metabolism have helped shape the development of safer and more effective drugs.His teaching has influenced countless students who have gone on to pursue successful careers in pharmacy and related fields. Through his mentorship, he has cultivated a generation of researchers and professionals who continue to contribute to the pharmaceutical sciences. His dedication to both teaching and research makes him a well-rounded academic whose influence is felt both inside and outside the classroom. 🎓

Legacy and Future Contributions 🌟

As a seasoned academic and researcher, Prof. Neerati Prasad’s legacy in the field of pharmaceutical sciences is already well-established. However, his journey is far from over. With a continued focus on cutting-edge research in Tumor Glycomics, Drug Transport, and Cancer Metastasis, his work holds the promise of further breakthroughs in these critical areas of healthcare. His research on the Pharmacological Screening of New Chemical Entities from Natural Sources is likely to lead to the discovery of novel therapeutic agents, offering new hope for the treatment of various diseases.In the years to come, Prof. Prasad’s influence will continue to grow as he inspires future generations of pharmacists and researchers. His commitment to advancing pharmaceutical sciences, both in India and internationally, ensures that his contributions will leave a lasting legacy. 🌍

Citations

A total of 667 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         667
  • h-index           41
  • i10-index        16

Notable Publications 

  • Title: A New Epoxy Steroid Isolated and Characterized from Bufo melanostictus Venom with Potential IL-6 along with TNF-α Inhibition and Spectroscopic Study for Structure and Vibrational Properties Using DFT
    Authors: Bonagani, N., Neerati, P., Prashanth, J., Byru, V.R.
    Journal: Journal of Molecular Structure
    Year: 2024.
  • Title: Hypoxia and Extracellular Matrix – Major Drivers of Tumor Metastasis
    Authors: Neerati, P., Polati, D.
    Journal: Hypoxia in Cancer: Significance and Impact on Cancer Therapy (Book Chapter)
    Year: 2023.
  • Title: Novel Indole Derivative as the First P-glycoprotein Inhibitor from the Skin of Indian Toad (Bufo melanostictus)
    Authors: Neerati, P., Munigadapa, S.
    Journal: Turkish Journal of Pharmaceutical Sciences
    Year: 2022.
  • Title: A New Steroidal Derivative from the Skin of Indian Toad (Bufo melanostictus) as a Hypolipidemic and CYP 3A Inhibitor
    Authors: Munigadapa, S.K., Neerati, P.
    Journal: Tropical Journal of Pharmaceutical Research
    Year: 2022.
  • Title: Gallic Acid Improved Amytryptiline Effect in Neuropathic Pain Induced by Partial Sciatic Nerve Ligation (Psnl) in Rats
    Authors: Neerati, P., Enumula, V.
    Journal: Natural Products Journal
    Year: 2021.

Mohhammad Ramzan | Pharmacology | Best Researcher Award

Dr. Mohhammad Ramzan | Pharmacology | Best Researcher Award

School of Pharmaceutical Sciences-India

Author Profile

Early Academic Pursuits

Dr. Mohhammad Ramzan began his academic journey in the field of pharmaceutical sciences with a commitment to excellence and innovation. He obtained his Bachelor of Pharmacy from Punjabi University, Patiala, in 2007, laying a strong foundation in pharmaceutical principles. His thirst for knowledge propelled him to pursue a Master of Pharmacy in Pharmaceutics from the same university, graduating in 2009. Dr. Ramzan’s academic journey culminated with a Ph.D. from Panjab University, Chandigarh, in 2023, where he focused on critical aspects of drug formulation and development. His dedication to understanding the intricacies of pharmaceuticals has been evident throughout his studies, marking him as a promising figure in the field. 📚

Professional Endeavors

With over 12 years of teaching and research experience, Dr. Ramzan has made significant contributions to pharmaceutical education and industry. Since August 2021, he has served as a Senior Research Associate Professor at the School of Pharmaceutical Sciences (SPS) at Lovely Professional University in Punjab, India. Prior to this, he was a Senior Research Fellow at the University Institute of Pharmaceutical Sciences (UIPS), Panjab University, where he contributed to various research projects from September 2015 to August 2021.His earlier roles included positions as an Assistant Professor at PCTE Institute of Pharmacy and as a Lecturer at Adesh Institute of Pharmacy and Biomedical Sciences. Dr. Ramzan’s diverse experiences in academia have allowed him to mentor numerous students, fostering a new generation of pharmaceutical scientists. 🎓

Contributions and Research Focus

Dr. Ramzan’s research interests are deeply rooted in Pharmaceutics, with a specialization in formulation development and optimization. His work includes the screening and optimization of formulation excipients using Design of Experiments (DoE) and Quality by Design (QbD) software. He has conducted extensive solubility analysis of active pharmaceutical ingredients (APIs) in various solvents using GastroPlus software, which is crucial for developing effective drug formulations.Additionally, Dr. Ramzan has made significant advancements in nanoparticulate technology, aiming to improve the biopharmaceutical performance of topical and parenteral antifungal agents. His research also encompasses toxicity testing in accordance with OECD guidelines, ensuring that pharmaceutical products are safe for consumer use.Dr. Ramzan has collaborated on industrial projects, notably developing lipidic nanocarriers for treating topical fungal infections in partnership with Hitech Formulation and the Biotechnology Industry Research Assistance Council (BIRAC). His research outcomes include six postgraduate theses, 27 publications, one international book chapter, and numerous conference presentations, showcasing his prolific contributions to the field. 💡

Accolades and Recognition

Dr. Ramzan’s work has garnered significant recognition in the academic community. He was awarded the UGC-BSR Fellowship in Sciences from 2015 to 2020 at Panjab University, acknowledging his research potential and contributions. His professional affiliations include being a life member of the Association of Pharmaceutical Teachers of India, reflecting his commitment to the advancement of pharmaceutical education.His extensive publication record, which includes 27 research papers and participation in various national and international conferences, demonstrates his influence and reputation in the field. These accolades not only validate his expertise but also inspire his colleagues and students alike. 🌟

Impact and Influence

Dr. Ramzan’s impact extends beyond his research and publications. By mentoring students and junior researchers, he plays a crucial role in shaping the future of pharmaceutical sciences. His focus on innovative drug delivery systems and formulation technologies directly addresses critical healthcare needs, particularly in treating resistant infections.Moreover, Dr. Ramzan actively engages with the pharmaceutical industry, bridging the gap between academia and practical applications. His collaborative projects aim to translate research findings into real-world solutions, significantly influencing the pharmaceutical landscape in India. 🌍

Legacy and Future Contributions

Looking ahead, Dr. Ramzan envisions expanding his research in pharmaceutics and drug formulation. He aims to explore new avenues in nanotechnology and sustainable pharmaceutical practices, focusing on developing safer and more effective medications. His commitment to fostering collaboration between academic institutions and the pharmaceutical industry is expected to lead to innovative solutions that enhance patient care.As he continues to inspire and educate future pharmacists, Dr. Mohhammad Ramzan’s legacy in the field of pharmaceutical sciences will undoubtedly be marked by his dedication to research, teaching, and the pursuit of excellence. Dr. Ramzan’s contributions are paving the way for advancements in pharmaceutical sciences, ensuring that his work will have a lasting impact on both the academic community and society at large.

Citations

A total of 214 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         214
  • h-index           30
  • i10-index        8

Notable Publications 

  • Ramzan, Mohhammad, Afzal Hussain, Tasneem Khan, Mohd Usman Mohd Siddique, Musarrat Husain Warsi.
    “Tolterodine tartrate loaded cationic elastic liposomes for transdermal delivery: in vitro, ex vivo, and in vivo evaluations.”
    Pharmaceutical Research, 2024.
  • Khan, Tasneem, Aziya Khan, Afzal Hussain, Ramzan, Mohhammad, Mudassar Shahid, Farhan Jalees Ahmad.
    “HSPiP and QbD oriented optimized green nanoemulsion to treat chloramphenicol contaminated water.”
    Journal of Molecular Liquids, 2024.
  • Jha, Ritwik Kumar and Ramzan, Mohhammad.
    “Biofabrication of nanoparticles: A Nature-inspired approach towards green synthesis.”
    European Journal of Cardiovascular Medicine, 2024.
  • Ramzan, Mohhammad, Mohammed Sabir, Sukhbir Singh, Abhijit Debnath.
    “Three-Dimensional Hydrogel Bioprinting Technology as a Scaffold of Novel Drug Delivery and Biomedical Devices: A Comprehensive Review.”
    BIO Web Conf., 2024.
  • Hussain, Afzal, Ramzan, Mohhammad*, Mohammad A. Altamimi, Tahir Khuroo, Mohd Usman Mohd Siddique, Osamah Abdulrahman Alnemer.
    “HSPiP, Computational Modeling, and QbD-Assisted Optimized Method Validation of 5‑Fluorouracil for Transdermal Products.”
    ACS Omega, 2024.

PRANJAL GUJARATHI | Pharmacology | Best Researcher Award

Dr. PRANJAL GUJARATHI | Pharmacology | Best Researcher Award

Vidhyadeep Institute of Pharmacy, Vidhyadeep Univeirsty,Surat India

Author Profile

Early Academic Pursuits 🎓📚

Pranjal Gujarathi’s academic journey in pharmacology began with a deep-rooted interest in the sciences. He pursued a focused path in pharmacy and pharmacology, equipping himself with the knowledge necessary to excel in drug research, pharmacodynamics, and pharmacokinetics. His formal education laid the foundation for his future contributions in understanding drug mechanisms and their effects on biological systems. His commitment to academic excellence ensured that he built a strong grounding in pharmacological principles, which later translated into valuable insights in the field of drug discovery and therapeutic innovations.

Professional Endeavors 🧑‍🔬👨‍🏫

Pranjal Gujarathi has had an impactful professional career in pharmacology, spanning teaching and research roles. He began his professional journey as an Assistant Professor of pharmacology at Shree Dhanvantry Pharmacy College in Surat, Gujarat, from July 27, 2017, to May 15, 2021. During his tenure, Pranjal played a pivotal role in mentoring students, designing course curricula, and advancing the department’s research objectives. His teaching covered various aspects of pharmacology, from drug development to therapeutic applications, helping shape the next generation of pharmacists and pharmacologists.In February 2022, Pranjal transitioned into a Junior Research Fellow position at the same institution, a role that allowed him to dive deeper into pharmacological research. His current work focuses on exploring novel drug therapies, pharmacogenomics, and the development of more effective and safer medications. This shift from teaching to dedicated research underscores his versatility and his dedication to pushing the boundaries of pharmacological knowledge.

Contributions and Research Focus 🔬💉

Pranjal Gujarathi’s research has primarily revolved around drug discovery, preclinical studies, and pharmacodynamics, areas where he has made significant contributions. His work emphasizes the understanding of drug-receptor interactions, drug metabolism, and toxicology, all of which are crucial in the early stages of drug development. His role as a Junior Research Fellow allows him to collaborate with other scientists to test the efficacy and safety of new drug formulations before they enter clinical trials.His research is also centered on immunopharmacology and neuropharmacology, focusing on conditions like psoriasis and neurodegenerative diseases. These diseases represent significant challenges in pharmacotherapy, and Pranjal’s preclinical work has helped pave the way for potential breakthroughs in treatment. His expertise in pharmacokinetics, which studies how drugs move through the body, further enhances the precision of his research, allowing for more targeted and effective treatments.

Accolades and Recognition 🏆📜

Pranjal Gujarathi has been widely recognized for his contributions to pharmacology. His research has been published in esteemed journals such as International Immunopharmacology and Naunyn-Schmiedeberg’s Archives of Pharmacology. These publications highlight his growing influence in the scientific community, particularly in the areas of drug discovery in psoriasis and comprehensive studies on Hypericum perforatum in treating neurodegenerative diseases.His academic prowess and ability to translate complex pharmacological concepts into applied research have earned him accolades at conferences and symposia, where his papers have been well-received. These recognitions validate his dedication to advancing the field of pharmacology and underscore his commitment to improving public health through better pharmaceuticals.

Impact and Influence 🌍💊

Pranjal’s influence extends beyond the confines of academia and research. As an educator, he has inspired countless students to pursue careers in pharmacology, instilling in them a rigorous understanding of drug mechanisms and their therapeutic uses. His role in preclinical research has contributed to the development of safer, more effective drugs, influencing the way treatments for chronic diseases like psoriasis are approached.His research on the pharmacological properties of natural products like Hypericum perforatum has opened new avenues in understanding plant-based therapies, potentially offering more accessible and less invasive treatment options for complex conditions. This focus on both synthetic and natural compounds ensures that his work remains relevant across a broad spectrum of pharmacology.

Legacy and Future Contributions 🚀🔝

As Pranjal Gujarathi continues his journey in pharmacological research, his contributions are likely to have a lasting impact on the field. His focus on innovative drug therapies, coupled with his dedication to teaching, positions him as a significant figure in both the academic and scientific communities. His legacy will be defined not only by the drugs developed under his research but also by the knowledge and inspiration he imparts to his students and colleagues.Looking forward, Pranjal is set to make further strides in drug safety evaluations, exploring new territories in personalized medicine and pharmacovigilance. His work has the potential to revolutionize how we understand drug interactions and their effects on different populations, leading to more personalized and effective treatments for patients around the world.

Conclusion 🌟👨‍⚕️

Pranjal Gujarathi’s journey in pharmacology is a testament to his dedication, intellect, and passion for the field. From his early academic pursuits to his significant professional contributions, he continues to influence the development of new drugs and therapies, pushing the boundaries of what’s possible in pharmacological research. With a future that promises even more innovations, Pranjal’s work is sure to leave a lasting legacy in the realm of pharmaceutical sciences.

Notable Publications 

  • Title: Preclinical techniques for drug discovery in psoriasis
    Authors: Gujarathi, P.P., Korat, R.H., Gujarathi, P.S.
    Journal: International Immunopharmacology
    Year: 2024.
  • Title: Hypericum perforatum: A comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative diseases
    Authors: Suryawanshi, M.V., Gujarathi, P.P., Mulla, T., Bagban, I.
    Journal: Naunyn-Schmiedeberg’s Archives of Pharmacology
    Year: 2024.
  • Title: Evaluation of acute intravenous toxicity of HEPES: Is Good’s buffer good and safe enough for clinical utilization in nuclear medicine?
    Authors: Guleria, M., Pallavi, K.J., Gujarathi, P.P., Das, T.
    Journal: Nuclear Medicine and Biology
    Year: 2024.

Manish Pal Singh | Pharmacology | Best Researcher Award

Dr. Manish Pal Singh | Pharmacology | Best Researcher Award

Sharda School of Pharmacy, Sharda University, Agra-India

Author Profile

Early Academic Pursuits 🎓

Dr. Manish Pal Singh embarked on his academic journey with a passion for pharmacology. He earned his Bachelor of Pharmacy degree in June 2006 from Rajiv Academy for Pharmacy, Mathura, affiliated with Uttar Pradesh Technical University, Lucknow, where he achieved 64%. Building on his foundation, Dr. Singh pursued his Master of Pharmacy in Pharmacology from B.N. College of Pharmacy, Udaipur. His dedication to academic excellence was evident when he graduated in December 2008 with 73%. His thirst for knowledge didn’t stop there; he went on to achieve his Ph.D. in Pharmacology from the Faculty of Pharmaceutical Sciences, Bhupal Nobles University, Udaipur, completing his doctorate in March 2020.

Professional Endeavors 🧑‍🔬

Dr. Manish Pal Singh’s professional career is marked by his leadership and expertise in pharmacology. His role as a researcher and educator has been pivotal in shaping the future of aspiring pharmacists. His guidance and supervision of numerous Ph.D. and postgraduate projects reflect his commitment to nurturing young minds in the field. Notable among these are projects that explore topics like myocardial infarction, anticonvulsant activity, anti-inflammatory compounds, type 2 diabetes, and wound healing.With his in-depth knowledge of pharmacology, Dr. Singh has successfully supervised numerous Ph.D. scholars and postgraduate students, including Mr. Soumyadip Mukherjee, working on myocardial infarction, Ms. Varsha Snehi on anticonvulsant activities, and Mr. Hritik Verma on anti-inflammatory potential of heterocyclic compounds.

Contributions and Research Focus 🧑‍🏫

Dr. Singh’s research primarily focuses on the pharmacological evaluation of novel compounds, drug synthesis, and exploring the medicinal properties of natural substances. Some of his notable work includes evaluating Launea sarmentosa for Type 2 Diabetes Mellitus (T2DM) and studying the antioxidant and antibacterial properties of Shorea Robusta Resin.He has also supervised research on plants like Amaranthus polygamus for anti-diabetic properties and conducted significant work on stress models in rats using compounds like Vitis Vinifera and Withania Somnifera. His research extends to wound healing, diabetes management, and the exploration of pharmacological potential in various medicinal plants.

Accolades and Recognition 🏅

Dr. Singh’s contributions to the field of pharmacology have been recognized through various grants and awards. He has been honored with two significant grants from the DST (SERB), New Delhi, for organizing conferences and seminars, receiving INR 100,000 in both 2019 and 2022. His academic excellence during his M.Pharm was acknowledged with appreciation certificates across multiple semesters, underlining his dedication and leadership in his field.Moreover, Dr. Singh has published extensively in both national and international journals. His impressive publication record includes 42 articles (21 research papers and 21 review articles) and 27 articles indexed in Scopus and SCI/ESCI. He has also contributed 7 book chapters and presented his research in 21 posters and 5 oral presentations at various conferences.

Impact and Influence 💡

Dr. Singh’s research has a significant impact, with his Google Scholar citations reaching 573 and an H-index of 14. His i10-index stands at 15, indicating the high quality and influence of his research work in the academic community. Additionally, his Scopus H-index is 5, further demonstrating his contributions to the global scientific discourse.His work on pharmacological instruments and animal modeling has equipped him with the practical skills necessary for cutting-edge research. Dr. Singh is also well-versed in documentation processes for NAAC, PCI, and BOS, which has proven beneficial in managing academic and research programs.

Legacy and Future Contributions 🌟

Dr. Manish Pal Singh is not only shaping the present but also influencing the future of pharmacology. His leadership in project coordination and his positive approach to decision-making make him a valuable mentor to his students and colleagues. As he continues to guide doctoral and postgraduate research, Dr. Singh’s contributions will have a lasting impact on pharmacological research, both in India and internationally.Through his work on biological screening of drugs, virtual experimental pharmacological screening, and his hands-on experience with sophisticated pharmacological instruments, Dr. Singh ensures that his students are well-prepared for the future of research and innovation.

Citations

A total of 110 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations        110
  • h-index           22
  • i10-index        5

Notable Publications 

  • Pharmacological update on Benincasa Hispida (Thunb.): A review
    • Authors: Singh, S., Gohil, K.J., Singh, M.P.
    • Journal: Pharmacological Research – Modern Chinese Medicine
    • Year: 2024.
  • Phytochemical and pharmacological aspects of genus Amaranthus
    • Authors: Singh, M.P., Goel, B., Kumar, R., Rathor, S.
    • Journal: Fitoterapia
    • Year: 2024.
  • Review on pharmacological activities of Justicia Gendarussa Burm F.
    • Authors: Jain, T., Singh, M.P., Bhardwaj, H., Gohil, K.J.
    • Journal: Pharmacological Research – Modern Chinese Medicine
    • Year: 2024.
  • Therapeutic Role of Desmodium Species on its Isolated Flavonoids
    • Authors: Singh, V., Singh, R., Singh, M.P., Katrolia, A.
    • Journal: Current Molecular Medicine
    • Year: 2024.
  • Autoimmunity and inflammation
    • Authors: Kumar, A., Chawla, V., Chawla, P.A., Singh, M.P., Singh, G.
    • Journal: Recent Developments in Anti-Inflammatory Therapy
    • Year: 2023.

Archana Kapoor | Pharmaceutical | Best Researcher Award

Prof. Archana Kapoor | Pharmaceutical | Best Researcher Award

Guru Jambheshwar University of Science & Technology-India

Author Profile

Early Academic Pursuits 📚

Born on October 25, 1978, Archana Kapoor embarked on her academic journey with a passion for pharmaceutical sciences. She pursued her undergraduate and postgraduate studies in Pharmaceutical Chemistry at Punjab University, Chandigarh, one of India’s premier institutions. Earning her post-graduation in 2003, she honed her expertise in drug discovery, medicinal chemistry, and pharmacokinetics. Her strong foundation in chemistry and pharmaceutical sciences earned her a GATE scholarship, a prestigious recognition of her academic excellence. Archana further enhanced her academic credentials by completing her Doctorate in Pharmaceutical Sciences from Guru Jambheshwar University of Science & Technology in 2016, marking a significant milestone in her pursuit of scientific knowledge and innovation.

Professional Endeavors 👩‍🔬

With almost 18 years of experience, Archana Kapoor’s career reflects her dedication to bridging the gap between academic research and industrial application. She commenced her professional journey in 2006 by joining Dr. Reddy’s Laboratories, Hyderabad, as a Scientist in the Discovery Chemistry section. During her tenure at Dr. Reddy’s, she gained invaluable experience in drug metabolism, pharmacokinetics, and advanced bioanalytical techniques such as HPLC and LC-MS/MS. Her work in the AMPK kinase project focused on developing lead series for Type-II Diabetes, contributing to the global efforts in combating this widespread condition.In 2016, Archana transitioned into academia, where she now serves as a Professor in the Department of Pharmaceutical Sciences at Guru Jambheshwar University of Science & Technology. Here, she plays a pivotal role in teaching, mentoring students, and spearheading research initiatives. Her ability to integrate real-world experience with academic learning has made her a respected figure among her peers and students alike.

Contributions and Research Focus 🔬

Archana Kapoor’s research portfolio is a testament to her deep commitment to advancing pharmaceutical sciences. Her work spans drug discovery, molecular docking, and pharmacokinetic analysis. One of her most significant contributions is her research on “5-Nitro-N-phenyl-3-(phenylamino)-1H-indazole-1-carboxamide Derivatives as Potential Anticancer Agents.” This study integrates chemical synthesis, in silico docking, and molecular dynamics simulations to explore new anticancer agents. The innovation in this research lies in its multi-faceted approach, targeting not just the synthesis of compounds but also analyzing their molecular interactions to optimize their efficacy as anticancer drugs.Her contributions to the discovery and development of new therapeutic agents extend beyond cancer treatment. While working at Dr. Reddy’s, Archana played a crucial role in the R&D sector, contributing to key projects that focused on metabolic disorders like Type-II Diabetes. Her experience with leading pharmaceutical companies and her academic background allows her to bring a comprehensive perspective to the challenges in drug discovery.

Innovations in Pharmaceutical Sciences 💡

Archana has consistently leveraged cutting-edge technology in her research, particularly in the integration of computational methods with experimental data. Her use of in silico techniques for drug discovery, including molecular docking and simulations, has streamlined the identification of promising drug candidates, saving both time and resources. By combining computational approaches with traditional experimental methods, Archana’s research has opened new avenues for discovering efficient and targeted therapeutic solutions.Her innovative methodologies reflect her forward-thinking approach and her drive to push the boundaries of pharmaceutical research. This integration of technology into drug discovery processes ensures that her work not only meets current scientific standards but also sets the stage for future advancements in the field.

Accolades and Recognition 🏆

Throughout her career, Archana Kapoor has been recognized for her exceptional contributions to pharmaceutical sciences. She has been the recipient of several awards and honors, including a prestigious Award of Honour for her exemplary efforts in education and research. Her research publications in renowned scientific journals and her presentations at international conferences have further solidified her standing as a leader in her field.Her work has also earned her recognition within the scientific community for her research on novel anticancer agents. The synthesis and analysis of new chemical compounds that can potentially contribute to cancer treatment has positioned her as an influential voice in pharmaceutical research. Additionally, her GATE scholarship during her postgraduate studies underscores her academic brilliance and commitment to excellence.

Impact and Influence 🌍

Archana Kapoor’s impact extends beyond her own research; she has become a mentor and a guide for the next generation of pharmaceutical scientists. As a professor, she has not only imparted knowledge but has also encouraged her students to engage in innovative thinking and research. Her leadership in various academic and research initiatives at Guru Jambheshwar University has led to the establishment of strong research networks and collaborations, fostering a culture of inquiry and innovation.Her participation in seminars, workshops, and conferences has further contributed to knowledge dissemination and professional networking. She has been instrumental in organizing academic events that bring together experts from various fields to discuss advancements in pharmaceutical sciences. Through these efforts, Archana has become a key figure in the pharmaceutical academic community, influencing both her peers and her students.

Legacy and Future Contributions 🌱

Looking ahead, Archana Kapoor is committed to continuing her research in drug discovery, with a specific focus on developing new therapeutic agents for cancer and metabolic diseases. Her interdisciplinary approach, combining chemistry, pharmacology, and computational methods, promises to drive future innovations in pharmaceutical research.In addition to her research contributions, Archana aims to continue her mentorship role, guiding young scientists and researchers in their academic and professional journeys. Her legacy is not only defined by her own research achievements but also by the impact she has had on shaping the future of pharmaceutical sciences through her students.

Citations

A total of 208 citations for his publications, demonstrating the impact and recognition of his research within the academic community.

  • Citations         208
  • h-index           8
  • i10-index        6

Notable Publications 

  • Exploration of N‐(6‐Indazolyl) Benzenesulfonamide Derivatives as Potential Antioxidants and Antimicrobial Agents: Integrating Synthesis, In Silico Docking, and Bioactivity
    Authors: M. Yadav, R. Rao, S. Kumar, A. Kapoor
    Journal: ChemistrySelect, Vol. 8 (45), 2023
  • Development of 2-Dimensional and 3-Dimensional QSAR Models of Indazole Derivatives as TTK Inhibitors Having Anticancer Potential
    Authors: A.K. Mithlesh Yadav, Balasubramanian Narasimhan
    Journal: Current Chemistry Letters, Vol. 13 (1), 2023
  • Hybrid Descriptors–Conjoint Indices: A Case Study on Imidazole-Thiourea Containing Glutaminyl Cyclase Inhibitors for Design of Novel Anti-Alzheimer’s Candidates
    Authors: K. Bagri, A. Kapoor, P. Kumar, A. Kumar
    Journal: SAR and QSAR in Environmental Research, Vol. 34 (5), 2023
  • Anti-Hyperglycemic Evaluation of 2,4-Thiazolidinedione and Rhodanine Derivatives
    Authors: A. Kapoor, N. Khare
    Journal: Der Pharma Chemica, Vol. 8 (12), 2016
  • A Review on the Drug Delivery Strategies for Parasitic Infections: Scope and Assertion
    Authors: M. Bhatia, S. Kumar, A. Kapoor, S. Lohan
    Journal: Drug Delivery Letters, Vol. 12 (2), 2022.

Konduru Ashok Kumar Raju | Biomaterials | Editorial Board Member

Dr. Konduru Ashok Kumar Raju - Biomaterials - Editorial Board Member 🏆 

National Institute of Technology Rourkela - India

Professional Profiles

Early Academic Pursuits

His academic journey began with a strong foundation in mechanical engineering, earning his Bachelor's and Master's degrees from Jawaharlal Nehru Technological University. His research interests expanded into CAD/CAM and heat transfer during his postgraduate studies. Pursuing his Ph.D. in Biomaterials at the National Institute of Technology, Rourkela, he delved into material science and engineering, focusing on functionalized coatings to improve corrosion resistance and biocompatibility of medical implants.

Professional Endeavors

With over five years of teaching experience in mechanical engineering departments, he has honed his skills as an educator. He has served as an Assistant Professor in esteemed institutions like JNTUA College of Engineering and Sri Krishnadevaraya Engineering College, imparting knowledge and mentoring students. Additionally, he has contributed significantly to the field of biomaterials as a scientific peer reviewer for reputable journals, including Elsevier and Wiley.

Contributions and Research Focus in Biomaterials

His research focuses on the development of functionalized coatings for medical implants, particularly titanium alloys like Ti6Al4V. These coatings aim to enhance corrosion resistance and biocompatibility, crucial factors in ensuring the success of medical implants. His work intersects material science, engineering, and biomedicine, contributing to advancements in biomaterials for medical applications. Raju's expertise also extends to CAD/CAM, tissue engineering, and regenerative medicine, reflecting his multidisciplinary approach to research.

Accolades and Recognition

His dedication to research and academic excellence has been recognized through various awards and honors. He was awarded the prestigious Sir M. Visveswaraya Best Engineering National Award and received scholarships from the State Council of Higher Education, Andhra Pradesh. Furthermore, he is a recipient of the National Ministry of Human Resource and Development Fellowship, highlighting his significant contributions to the field of biomaterials.

Impact and Influence

Through his research and academic pursuits, he has made a significant impact on the field of biomaterials and medical engineering. His work has the potential to improve the performance and longevity of medical implants, ultimately benefiting patients worldwide. As a scientific peer reviewer, he plays a vital role in maintaining the quality and integrity of scholarly publications, shaping the discourse in biomaterials research.

Legacy and Future Contributions

Looking ahead, His legacy lies in his commitment to advancing biomaterials and medical engineering. His research endeavors aim to address pressing challenges in the field, such as improving the biocompatibility of implants and developing novel materials for tissue engineering applications. Through continued collaboration, innovation, and mentorship, he seeks to inspire future generations of researchers and contribute to transformative advancements in healthcare.

Citations

  • Citations              37
  • h-index                 4

Notable Publications